arXiv Science⌕ Search

arXiv · 2611.18970

A Distributionally Robust Framework for Safe and Generalizable Utilization of Surrogate Markers

Abstract

Surrogate endpoints can accelerate treatment evaluation, but their validity is challenging to establish because the joint distribution of counterfactual outcome surrogate pairs is not identifiable. We propose a distributionally robust framework for safe and generalizable surrogate evaluation that explicitly accounts for this uncertainty. By treating cross arm dependence as partially identified, we formulate a maximin optimization problem that learns an optimal surrogate transformation by maximizing the worst case explained variance of individual treatment effects over admissible counterfactual dependence structures. The resulting robust surrogacy measure provides a conservative lower bound on explained treatment effect variation. Moreover, our maximin construction guarantees nonnegative alignment between the treatment effects on the transformed surrogate and the primary outcome over the admissible counterfactual couplings. To generalize surrogacy evaluation across populations under covariate shift, we integrate transfer learning with debiased machine learning to estimate the required target population moments using source trial data and target baseline covariates. The computational tractability and asymptotic properties of our method are established. Simulations demonstrate good finite sample performance and show that the proposed method guards against counterfactual misalignment by shrinking the learned transformation toward zero, revealing a robustness prediction tradeoff. We illustrate the framework by evaluating 18 month glomerular filtration rate change as a surrogate for two year change using multiple randomized clinical trial data sets.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Molei Liu, Tian Jiang, Keyao Zhan, Zirui Zhang, Xuan Wang. 2026-11-13. A Distributionally Robust Framework for Safe and Generalizable Utilization of Surrogate Markers. https://arxiv.science/abs/2611.18970

Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite arXiv Science by Indiciae: BibTeX · RIS.

KEEP EXPLORING

Related papers

Statistical Performance Guarantee for Subgroup Identification with Generic Machine Learning

Across a wide array of disciplines, many researchers use machine learning (ML) algorithms to identify a subgroup of individuals who are likely to benefit from a treatment the most (``exceptional responders'') or those who are harmed by it. A common approach to this subgroup identification problem consists of two steps. First, researchers estimate the conditional average treatment effect (CATE) using an ML algorithm. Next, they use the estimated CATE to select those individuals who are predicted to be most affected by the treatment, either positively or negatively. Unfortunately, CATE estimates are often biased and noisy. In addition, utilizing the same data to both identify a subgroup and estimate its group average treatment effect results in a multiple testing problem. To address these challenges, we develop uniform confidence bands for estimation of the group average treatment effect sorted by generic ML algorithm (GATES). Using these uniform confidence bands, researchers can identify, with a statistical guarantee, a subgroup whose GATES exceeds a certain effect size, regardless of how this effect size is chosen. The proposed methodology uses random treatment assignment, random sampling of units, and continuity and moment conditions, without requiring consistency or monotonicity of the ML score. We derive a Wiener representation of the estimation error, with corrections for the empirical subgroup threshold and the fixed treatment sample size. Estimating this representation gives asymptotically exact uniform coverage using Gaussian draws, without refitting the ML model. We also develop uniform bands for mean-adjusted treatment effects and other evaluation metrics. A simulation design and an application to a clinical trial of late-stage prostate cancer illustrate the subgroup identification problem.

stat.ME↗

Collaborative Optimal Design of Controlled Experiments with Subject Covariates

Modern experimental design problems often encounter multiple controlled experiments with subjects participating in more than one experiment. It is of interest to consider the optimal design of allocating subjects to treatment or control for these experiments especially when subject covariate information is available. In this work, we propose an optimal allocation method to enable accurate estimates of treatment effects for all experiments. Deriving the precision matrix of the treatment effects and using D-optimality as our allocation criterion, we demonstrate the advantage of collaboratively designing and analyzing multiple experiments over traditional independent design and analysis, and propose efficient algorithms to design construction of the D-optimality problem for collaborative experiments. The performance of the proposed methods is examined by simulation studies and a case study involving online education experimentation.

stat.ME↗

Parameter-Specific Bias Diagnostics in Random-Effects Panel Data Models

The Hausman specification test assesses the random-effects specification by comparing random-effects and fixed-effects estimators. This note uses the diagnostic of Karl and Zimmerman (2021) to give a coefficient-specific sensitivity summary from one fitted mixed model. The diagnostic measures alignment between fitted random effects and the weights used to estimate a coefficient or contrast. Its value need not equal finite-sample bias: fitted effects are shrunken, and response-dependent covariance estimates introduce an additional weighted-error term. We explain this distinction, describe simulations that refit the covariance parameters and retain the latent-effect and weighted-error contributions, and illustrate the calculations with gasoline-demand data and a multiple-membership value-added model. Connecting the diagnostic to established generalized least squares sensitivity analysis, including Vasnev's (2010) balanced-panel results, we identify it as the negative derivative of a coefficient or contrast with respect to the log scale of the random-effects covariance. With fitted covariance shapes held fixed, integrating the diagnostic over this log scale, upward from the fitted model, gives the random-effects estimate minus the fixed-effects estimate for a contrast estimable under both models. We also discuss conditioning on stochastic regressors and the additional assumptions needed for calibrated inference.

stat.ME↗